Herceptin Should Be Used With Caution In Pulmonary Compromised Patients
Executive Summary
Genentech is revising Herceptin labeling to add warnings about fatal hypersensitivity, infusion and pulmonary reactions in breast cancer patients being treated with the anti-HER2 oncologic.